Annual CFI
$24.37 M
+$53.21 M+184.51%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual cash flow from investing activities is $24.37 million, with the most recent change of +$53.21 million (+184.51%) on December 1, 2023.
- During the last 3 years, CATX annual CFI has risen by +$24.78 million (+6044.63%).
- CATX annual CFI is now at all-time high.
Performance
CATX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$29.74 M
-$26.44 M-802.49%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly cash flow from investing activities is -$29.74 million, with the most recent change of -$26.44 million (-802.49%) on September 1, 2024.
- Over the past year, CATX quarterly CFI has dropped by -$29.51 million (-13000.00%).
- CATX quarterly CFI is now -217.71% below its all-time high of $25.26 million, reached on March 31, 2023.
Performance
CATX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$80.42 M
-$29.51 M-57.97%
September 1, 2024
Summary
- As of February 7, 2025, CATX TTM cash flow from investing activities is -$80.42 million, with the most recent change of -$29.51 million (-57.97%) on September 1, 2024.
- Over the past year, CATX TTM CFI has dropped by -$104.88 million (-428.75%).
- CATX TTM CFI is now -428.75% below its all-time high of $24.46 million, reached on September 30, 2023.
Performance
CATX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CATX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +184.5% | -10000.0% | -428.8% |
| 3 y3 years | +6044.6% | -217.7% | -702.0% |
| 5 y5 years | +5978.1% | -217.7% | -702.0% |
CATX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +184.5% | -217.7% | +37.1% | -428.8% | at low |
| 5 y | 5-year | at high | +184.5% | -217.7% | +37.1% | -428.8% | at low |
| alltime | all time | at high | +184.5% | -217.7% | +37.1% | -428.8% | at low |
Perspective Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.74 M(+802.5%) | -$80.42 M(+58.0%) |
| Jun 2024 | - | -$3.29 M(-93.0%) | -$50.91 M(+5.6%) |
| Mar 2024 | - | -$47.30 M(>+9900.0%) | -$48.19 M(-297.7%) |
| Dec 2023 | $24.37 M(-184.5%) | -$89.00 K(-60.8%) | $24.37 M(-0.4%) |
| Sep 2023 | - | -$227.00 K(-60.4%) | $24.46 M(-333.5%) |
| Jun 2023 | - | -$573.00 K(-102.3%) | -$10.48 M(+4.5%) |
| Mar 2023 | - | $25.26 M(-171.8%) | -$10.03 M(-71.7%) |
| Dec 2022 | -$28.84 M(>+9900.0%) | - | - |
| Sep 2022 | - | -$35.17 M(>+9900.0%) | -$35.40 M(>+9900.0%) |
| Jun 2022 | - | -$123.00 K(+373.1%) | -$284.00 K(-5.0%) |
| Jun 2022 | -$284.00 K(-30.7%) | - | - |
| Mar 2022 | - | -$26.00 K(-67.9%) | -$299.00 K(-19.6%) |
| Dec 2021 | - | -$81.00 K(+50.0%) | -$372.00 K(+6.0%) |
| Sep 2021 | - | -$54.00 K(-60.9%) | -$351.00 K(-14.4%) |
| Jun 2021 | -$410.00 K(+42.9%) | - | - |
| Jun 2021 | - | -$138.00 K(+39.4%) | -$410.00 K(+31.8%) |
| Mar 2021 | - | -$99.00 K(+65.0%) | -$311.00 K(+21.5%) |
| Dec 2020 | - | -$60.00 K(-46.9%) | -$256.00 K(-15.2%) |
| Sep 2020 | - | -$113.00 K(+189.7%) | -$302.00 K(+5.2%) |
| Jun 2020 | -$287.00 K(-171.6%) | -$39.00 K(-11.4%) | -$287.00 K(-114.4%) |
| Mar 2020 | - | -$44.00 K(-58.5%) | $1.99 M(-53.0%) |
| Dec 2019 | - | -$106.00 K(+8.2%) | $4.24 M(-35.7%) |
| Sep 2019 | - | -$98.00 K(-104.4%) | $6.59 M(+1543.9%) |
| Jun 2019 | $401.00 K(-78.4%) | $2.24 M(+1.5%) | $401.00 K(-163.0%) |
| Mar 2019 | - | $2.21 M(-1.8%) | -$637.00 K(-72.9%) |
| Dec 2018 | - | $2.25 M(-135.7%) | -$2.35 M(-42.9%) |
| Sep 2018 | - | -$6.29 M(-623.6%) | -$4.12 M(-321.4%) |
| Jun 2018 | $1.86 M(+22.8%) | $1.20 M(+143.1%) | $1.86 M(-31.2%) |
| Mar 2018 | - | $494.00 K(+3.1%) | $2.70 M(+27.1%) |
| Dec 2017 | - | $479.00 K(-252.1%) | $2.13 M(+39.3%) |
| Sep 2017 | - | -$315.00 K(-115.4%) | $1.53 M(+0.8%) |
| Jun 2017 | $1.51 M(-82.7%) | $2.04 M(-2563.9%) | $1.51 M(-70.4%) |
| Mar 2017 | - | -$83.00 K(-31.4%) | $5.12 M(-53.3%) |
| Dec 2016 | - | -$121.00 K(-63.0%) | $10.97 M(-0.3%) |
| Sep 2016 | - | -$327.00 K(-105.8%) | $11.01 M(+25.7%) |
| Jun 2016 | $8.76 M(+1017.0%) | $5.65 M(-2.0%) | $8.76 M(+12.2%) |
| Mar 2016 | - | $5.77 M(-6729.9%) | $7.80 M(+168.1%) |
| Dec 2015 | - | -$87.00 K(-96.6%) | $2.91 M(+0.9%) |
| Sep 2015 | - | -$2.58 M(-154.8%) | $2.88 M(+267.9%) |
| Jun 2015 | $784.00 K(-105.1%) | $4.70 M(+437.0%) | $783.90 K(-104.1%) |
| Mar 2015 | - | $875.10 K(-871.7%) | -$19.34 M(-4.4%) |
| Dec 2014 | - | -$113.40 K(-97.6%) | -$20.22 M(+0.5%) |
| Sep 2014 | - | -$4.68 M(-69.7%) | -$20.11 M(+30.3%) |
| Jun 2014 | -$15.44 M | -$15.42 M(>+9900.0%) | -$15.44 M(>+9900.0%) |
| Mar 2014 | - | -$5500.00(-51.8%) | -$21.30 K(+39.2%) |
| Dec 2013 | - | -$11.40 K(+147.8%) | -$15.30 K(+45.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$4600.00(-2400.0%) | -$10.50 K(-18.0%) |
| Jun 2013 | -$12.80 K(-86.6%) | $200.00(-60.0%) | -$12.80 K(-67.5%) |
| Mar 2013 | - | $500.00(-107.6%) | -$39.40 K(-51.5%) |
| Dec 2012 | - | -$6600.00(-4.3%) | -$81.30 K(-6.0%) |
| Sep 2012 | - | -$6900.00(-73.9%) | -$86.50 K(-9.4%) |
| Jun 2012 | -$95.50 K(-39.5%) | -$26.40 K(-36.2%) | -$95.50 K(-21.1%) |
| Mar 2012 | - | -$41.40 K(+250.8%) | -$121.00 K(-20.5%) |
| Dec 2011 | - | -$11.80 K(-25.8%) | -$152.20 K(-11.4%) |
| Sep 2011 | - | -$15.90 K(-69.4%) | -$171.70 K(+8.7%) |
| Jun 2011 | -$157.90 K(-109.6%) | -$51.90 K(-28.5%) | -$157.90 K(+34.0%) |
| Mar 2011 | - | -$72.60 K(+131.9%) | -$117.80 K(+138.9%) |
| Dec 2010 | - | -$31.30 K(+1390.5%) | -$49.30 K(-105.3%) |
| Sep 2010 | - | -$2100.00(-82.2%) | $931.30 K(-43.4%) |
| Jun 2010 | $1.64 M(-26.0%) | -$11.80 K(+187.8%) | $1.64 M(+287.2%) |
| Mar 2010 | - | -$4100.00(-100.4%) | $424.80 K(-89.2%) |
| Dec 2009 | - | $949.30 K(+33.4%) | $3.92 M(+32.6%) |
| Sep 2009 | - | $711.50 K(-157.8%) | $2.96 M(+33.2%) |
| Jun 2009 | $2.22 M(-12.3%) | -$1.23 M(-135.2%) | $2.22 M(-63.8%) |
| Mar 2009 | - | $3.50 M(<-9900.0%) | $6.13 M(+35.1%) |
| Dec 2008 | - | -$16.20 K(-36.0%) | $4.54 M(+13.3%) |
| Sep 2008 | - | -$25.30 K(-100.9%) | $4.01 M(+58.1%) |
| Jun 2008 | $2.53 M(-120.4%) | $2.68 M(+40.6%) | $2.53 M(-121.6%) |
| Mar 2008 | - | $1.90 M(-446.7%) | -$11.75 M(-15.8%) |
| Dec 2007 | - | -$549.10 K(-63.3%) | -$13.95 M(+0.8%) |
| Sep 2007 | - | -$1.50 M(-87.1%) | -$13.84 M(+11.4%) |
| Jun 2007 | -$12.42 M(+1383.0%) | -$11.60 M(+3778.4%) | -$12.42 M(+1246.5%) |
| Mar 2007 | - | -$299.20 K(-31.8%) | -$922.30 K(-2.0%) |
| Dec 2006 | - | -$438.50 K(+472.5%) | -$941.00 K(+55.4%) |
| Sep 2006 | - | -$76.60 K(-29.1%) | -$605.70 K(-27.7%) |
| Jun 2006 | -$837.40 K(<-9900.0%) | -$108.00 K(-66.0%) | -$837.40 K(+14.8%) |
| Mar 2006 | - | -$317.90 K(+208.0%) | -$729.40 K(+77.3%) |
| Dec 2005 | - | -$103.20 K(-66.5%) | -$411.50 K(+33.5%) |
| Sep 2005 | - | -$308.30 K(<-9900.0%) | -$308.30 K(<-9900.0%) |
| Jun 2005 | $0.00(0.0%) | - | - |
| Mar 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2004 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2000 | $0.00(-100.0%) | - | - |
| Sep 1999 | -$48.80 K(-69.1%) | -$13.20 K(<-9900.0%) | -$48.80 K(+37.1%) |
| Jun 1999 | - | $0.00(0.0%) | -$35.60 K(0.0%) |
| Mar 1999 | - | $0.00(-100.0%) | -$35.60 K(0.0%) |
| Dec 1998 | - | -$35.60 K | -$35.60 K |
| Sep 1998 | -$158.00 K(+532.0%) | - | - |
| Sep 1997 | -$25.00 K(+233.3%) | - | - |
| Sep 1996 | -$7500.00(-111.5%) | - | - |
| Sep 1995 | $65.20 K(-90.7%) | - | - |
| Sep 1994 | $698.90 K | - | - |
FAQ
- What is Perspective Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Perspective Therapeutics?
- What is Perspective Therapeutics annual CFI year-on-year change?
- What is Perspective Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly CFI year-on-year change?
- What is Perspective Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Perspective Therapeutics?
- What is Perspective Therapeutics TTM CFI year-on-year change?
What is Perspective Therapeutics annual cash flow from investing activities?
The current annual CFI of CATX is $24.37 M
What is the all time high annual CFI for Perspective Therapeutics?
Perspective Therapeutics all-time high annual cash flow from investing activities is $24.37 M
What is Perspective Therapeutics annual CFI year-on-year change?
Over the past year, CATX annual cash flow from investing activities has changed by +$53.21 M (+184.51%)
What is Perspective Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CATX is -$29.74 M
What is the all time high quarterly CFI for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly cash flow from investing activities is $25.26 M
What is Perspective Therapeutics quarterly CFI year-on-year change?
Over the past year, CATX quarterly cash flow from investing activities has changed by -$29.51 M (-13000.00%)
What is Perspective Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CATX is -$80.42 M
What is the all time high TTM CFI for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM cash flow from investing activities is $24.46 M
What is Perspective Therapeutics TTM CFI year-on-year change?
Over the past year, CATX TTM cash flow from investing activities has changed by -$104.88 M (-428.75%)